| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 59746-781-30 | 59746-781 | HUMAN PRESCRIPTION DRUG | Loperamide Hydrochloride | Loperamide Hydrochloride | CAPSULE | ORAL | 20230930 | N/A | ANDA | ANDA217840 | JUBILANT CADISTA PHARMACEUTICALS INC. | LOPERAMIDE HYDROCHLORIDE | 2 mg/1 | 30 CAPSULE in 1 BOTTLE (59746-781-30) |
| 59746-781-05 | 59746-781 | HUMAN PRESCRIPTION DRUG | Loperamide Hydrochloride | Loperamide Hydrochloride | CAPSULE | ORAL | 20230930 | N/A | ANDA | ANDA217840 | JUBILANT CADISTA PHARMACEUTICALS INC. | LOPERAMIDE HYDROCHLORIDE | 2 mg/1 | 500 CAPSULE in 1 BOTTLE (59746-781-05) |
| 59746-781-01 | 59746-781 | HUMAN PRESCRIPTION DRUG | Loperamide Hydrochloride | Loperamide Hydrochloride | CAPSULE | ORAL | 20230930 | N/A | ANDA | ANDA217840 | JUBILANT CADISTA PHARMACEUTICALS INC. | LOPERAMIDE HYDROCHLORIDE | 2 mg/1 | 100 CAPSULE in 1 BOTTLE (59746-781-01) |